Background: Aromatase deficiency is a rare autosomal recessive disorder that is caused by an impairment of androgen conversion to estrogens. Affected 46, XX individuals generally present with virilization of external genitalia at birth and mutations in CYP19A1 gene.

Objective: This study described the clinical features and molecular basis of a Chinese 46, XX girl born with ambiguous genitalia and investigated the functional alteration of two novel mutations of the CYP19A1 gene.

Methods And Results: Obvious prepartum virilization and remarkably elevated testosterone were observed in the mother, who was initially suspected to have a testosterone-producing ovarian tumor. Clinical phenotypes and hormone profiles of the patient and her mother were investigated. Genotyping analyses of the CYP19A1 gene were performed in the patient and her parents. Functional impairment of the mutations was explored using three-dimensional computer model and mutagenesises in vitro transfection assays. A compound heterozygous mutation of the CYP19A1 gene was revealed in the patient, with a G deletion in nucleotide 264 of exon 3 in one allele and a 23-bp insertion in exon 9 in another allele; both mutations resulted in reading frame-shifts that led to truncated proteins of 87 and 360 amino acids, respectively. Molecular modeling analysis suggested that the two renascent truncated proteins lacked crucial amino acids that were involved in substrate access and catalysis as well as heme-binding region. Functional studies in transfected HEK-293T cells exhibited a nearly complete abolishment of enzyme activity, which may underlie the phenotype and hormone profile.

Conclusions: Two novel CYP19A1 mutations were identified in a Chinese girl born with ambiguous genitalia and severe maternal virilization during pregnancy. Maternal virilization should prompt consideration of aromatase deficiency, preventing unnecessary interventions in pregnancy. This study broadens the spectrum of phenotype and genetic mutations of this rare disorder.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.mce.2016.05.025DOI Listing

Publication Analysis

Top Keywords

aromatase deficiency
12
chinese girl
12
maternal virilization
12
compound heterozygous
8
heterozygous mutation
8
identified chinese
8
mutations cyp19a1
8
girl born
8
born ambiguous
8
ambiguous genitalia
8

Similar Publications

Bone Disease Associated with Inactivating Aromatase Mutations and its Management.

Calcif Tissue Int

January 2025

Department of Medicine, Surgery and Neurosciences, University of Siena, Policlinico Santa Maria Alle Scotte, Siena, Italy.

Article Synopsis
  • Aromatase deficiency is a rare genetic disorder caused by mutations in the CYP19A1 gene, affecting both males and females, with an incidence of less than 1 in 1,000,000.
  • In females, symptoms typically present at birth or in early infancy, focusing on sexual development, while in males, issues usually emerge during or after puberty, leading to delayed diagnosis.
  • The paper reviews the skeletal and extraskeletal effects of the condition and discusses strategies for managing bone health in individuals with these mutations.
View Article and Find Full Text PDF
Article Synopsis
  • Differences of sex development (DSD) encompasses a range of congenital conditions affecting chromosomal, gonadal, and anatomical sex development, often linked to atypical hormonal exposure or internal genital abnormalities.
  • DSD can manifest in various clinical phenotypes, leading to diagnoses at birth, during adolescence due to changes in virilization, or pubertal delays.
  • This review highlights rare causes of 46,XX DSD beyond congenital adrenal hyperplasia (CAH), focusing on their genetic, clinical characteristics, as well as puberty and fertility outcomes.
View Article and Find Full Text PDF

Diagnosis and management of non-CAH 46,XX disorders/differences in sex development.

Front Endocrinol (Lausanne)

May 2024

Department of Pediatric Endocrinology and Diabetes, School of Medicine, Marmara University, Istanbul, Türkiye.

Article Synopsis
  • Prenatal exposure to androgens can disrupt sexual development in individuals with a 46,XX chromosome pattern, commonly leading to disorders/differences in sex development (DSD).
  • The majority of these cases are due to congenital adrenal hyperplasia (CAH) resulting from 21-hydroxylase deficiency, but there are rare forms of CAH and other genetic factors that can also contribute to 46,XX DSD.
  • The management of 46,XX DSD is complex due to uncertainties regarding gonadal function and gender outcomes, making diagnosis and treatment challenging.
View Article and Find Full Text PDF

Estradiol is an important regulator of bone accumulation and maintenance. Circulating estrogens are primarily produced by the gonads. Aromatase, the enzyme responsible for the conversion of androgens to estrogen, is expressed by bone marrow cells (BMCs) of both hematopoietic and nonhematopoietic origin.

View Article and Find Full Text PDF

Background: Aromatase deficiency is a rare disorder, with only a few cases reported in India. We describe a single-center experience in western India, with a systematic review of genetically proven 46,XX aromatase deficiency patients to evaluate hormonal parameters.

Methods: Retrospective review of case records, collating phenotypic and genotypic data and molecular modeling.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!